Search
Close this search box.

It’s Time to Future-Proof Your Covered Entity

The landscape for covered entities is changing quickly, and both the future of your business and the wellness of your patients is on the line.

Drastic federal cuts to the 340B program. Alarming changes to Gilead’s Advancing Access Program. If your organization is a federal grantee or health system providing HIV care and/or prevention services, you know there has never been a more important time to future-proof your program—while still offering the highest standards of compassionate care.

What’s more, how entities provide care to their communities is quickly changing. Per CDC guidelines, providers are encouraged to prescribe PrEP to any patient who asks for it, and to have conversations about PrEP with all sexually active adolescent and adult patients. Telehealth is making care more accessible to rural communities, as well as eliminating some of the barriers and fears for patients who don’t feel comfortable in traditional health care settings.

Simply segmenting care into prevention and care categories is no longer going to cut it–and both the future of your business and the wellness of your patients is on the line.

What does all that mean for covered entities? It means the landscape is changing quickly, and there is an urgent need to consider the entire health care journey of all your patients, both those who are a part of the LGBTQ+ community and those who are not. Simply segmenting care into prevention and care categories is no longer going to cut it—and both the future of your business and the wellness of your patients is on the line.

 

Ready to read full article in 340B Report? Just click here.

Glen Pietrandoni Headshot

Glen Pietrandoni

Chief Advocacy Officer, Avita Care Solutions
Glen is chief advocacy officer at Avita Care Solutions and an award-winning pharmacy leader, internationally respected HIV and LGBTQ+ activist, and passionate 340B program advocate. He’s deeply engaged in Avita’s mission to strengthen health equity among marginalized communities and works to bring together stakeholders from the pharmaceutical industry and patient advocacy arenas. Through webinars, conferences, Avita’s thought leadership blog series “The Take,” and the organization’s engagement with multiple community and trade associations, Glen leads Avita’s educational and awareness efforts and acts as a voice for its covered entity partners and patients. Leveraging his unique insights into how the integration of pharmacy services, telehealth, and brick-and-mortar care can remove barriers in the patient journey, Glen continually advances stigma-free HIV, PrEP, LGBTQ+, and sexual wellness care among underserved populations. In 2022, Glen received Pharmacy Times’ Lifetime Leadership honor at the Next-Generation Pharmacist awards. He serves on the Board of Pharmacy for the State of Illinois, was formerly chairman of the Board of Trustees of AIDS United, and helps lead the board of Community Voices for 340B (CV340B). He has earned American Academy of HIV Medicine and Apexus 340B certifications.

Share

Sign up to receive the latest news from Avita Care Solutions

Sign up to receive the latest news from Avita Care Solutions

The latest from Avita

Avita Pride Campaign 2024

Pride ‘24/7: Announcing Our 2024 LGBTQ+ Pride Schedule

How covered entities can engage behavioral health patients

How Covered Entities Can Engage Behavioral Health Patients

STI Epidemic David Harvey Dr. Christopher Hall Avita

The Take: Why the U.S. STI Epidemic is “Out of Control”

Explore Categories